SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-019344
Filing Date
2023-03-13
Accepted
2023-03-13 06:14:29
Documents
12
Period of Report
2023-03-13
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea175068-8k_aditxt.htm   iXBRL 8-K 26953
  Complete submission text file 0001213900-23-019344.txt   202072

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE adtx-20230313.xsd EX-101.SCH 3221
3 XBRL LABEL FILE adtx-20230313_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE adtx-20230313_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT ea175068-8k_aditxt_htm.xml XML 3693
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 23725609
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences